In an article published in the prestigious Accounts in Chemical Research, Wyss Institute Founding Director Donald Ingber, M.D., Ph.D., and his sensor team led by Senior Staff Scientist Pawan Jolly, Ph.D. in the Wyss Institute’s Bioinspired Therapeutics & Diagnostics Platform, describe the development and evolution of their eRapid affinity-based electrochemical sensor platform that is beginning to be applied to enable versatile and multiplexed low-cost point-of-care (POC) diagnostics for different hard-to-detect diseases and disorders.
